[Vaccination in rheumatology: Evolution of views on the problem].

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Терапевтический архив

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.17116/terarkh201789583-89PMID 28631705
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influenza Vaccination in Patients With Rheumatic Diseases

  2017cited by this paper
• The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis

  2015cited by this paper
• Оценка иммуногенности и безопасности 23-валентной полисахаридной пневмококковой вакцины у больных ревматическими заболеваниями

  2015cited by this paper
• Immunization in Patients with Rheumatic Diseases: A Practical Guide for General Practitioners.

  2015cited by this paper
• Пневмония у пациентов на фоне онкологических заболеваний крови

  2014cited by this paper
• Vaccinations for Rheumatoid Arthritis

  2014cited by this paper
• Vaccines and biologics

  2014cited by this paper
• Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

  2014cited by this paper
• Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases

  2014cited by this paper
• Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA)

  2014cited by this paper
• Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

  2013cited by this paper
• Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)

  2013cited by this paper
• Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy

  2013cited by this paper
• Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs

  2013cited by this paper
• Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment.

  2012influential reference
• Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry.

  2012cited by this paper
• Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses

  2012cited by this paper
• Abatacept therapy and safety management.

  2012cited by this paper
• Clinical and epidemiological research

  2011cited by this paper
• Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

  2010cited by this paper
• Are Anti-Infectious Vaccinations Safe and Effective in Patients with Autoimmunity?

  2010cited by this paper
• EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

  2010cited by this paper
• Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study

  2010cited by this paper
• Correlates of Protection Induced by Vaccination

  2010cited by this paper
• Infection prophylaxis in antirheumatic therapy: emphasis on vaccination

  2009cited by this paper
• Abatacept therapy and safety management.

  2009cited by this paper
• Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease

  2008cited by this paper
• Immunization of patients with rheumatoid arthritis with antitumor necrosis factorα therapy and methotrexate

  2008cited by this paper
• The risk of hospitalized infection in patients with rheumatoid arthritis.

  2008cited by this paper
• Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis

  2007cited by this paper
• Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.

  2007cited by this paper
• Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis.

  2007cited by this paper
• Acute lower respiratory tract infections in patients with rheumatoid arthritis.

  2007cited by this paper
• Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis

  2006cited by this paper
• Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.

  2006cited by this paper
• Why have rheumatologists been reluctant to vaccinate patients with systemic lupus erythematosus?

  2006cited by this paper
• Infectious causes of death in patients with rheumatoid arthritis: an autopsy study

  2006cited by this paper
• Influenza vaccination of patients with systemic lupus erythematosus.

  2004cited by this paper
• Childhood immunizations and chronic illness.

  2004cited by this paper
• Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.

  2004cited by this paper
• Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy.

  2003cited by this paper
• Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study.

  2002cited by this paper
• Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis.

  2001cited by this paper
• Protective role of infections and vaccinations on autoimmune diseases.

  2001cited by this paper
• Antigen-specific antibody responses in lupus patients following immunization.

  1998cited by this paper
• The mortality of rheumatoid arthritis.

  1994cited by this paper
• Specific antibody response after in vivo antigenic stimulation in systemic lupus erythematosus.

  1984cited by this paper
• Influenza vaccination in patients with rheumatic diseases. Safety and efficacy.

  1979cited by this paper
• Influenza vaccination of patients with systemic lupus erythematosus.

  1978cited by this paper
• Influenzal vaccine response in systemic lupus erythematosus.

  1978cited by this paper
• Clinical and antibody responses after influenza immunization in systemic lupus erythematosus.

  1978cited by this paper
• Influenza immunization in systemic lupus eruthematosus. A double-blind trial.

  1978cited by this paper

• [The effectiveness of vaccination against pneumococcal infection in patients with severe bronchial asthma].

  2024cites this paper
• Scientific and practical interpretation of health as a basic socio-psychological conceptual category

  2022cites this paper
• Pneumococcal Vaccine in Patients with Systemic Juvenile Idiopathic Arthritis Receiving Biologic Therapy: International Practice Review

  2019cites this paper
• VACCINATION IN RHEUMATIC DISEASES: AN ALLY OR AN ENEMY?

  2018cites this paper